Rebirthel Co.,Ltd.

An independent biocompany, developing cellular immunotherapies for cancer, based on Kyoto.

General Information
Company Name
Rebirthel Co.,Ltd.
Founded Year
2019
Location (Offices)
Japan +1
Founders / Decision Makers
Number of Employees
3
Industries
Biotechnology, Health Care, Health and Wellness +1
Funding Stage
Series Unknown
Social Media

Rebirthel Co.,Ltd. - Company Profile

Rebirthel Co.,Ltd. is an independent biocompany based in Kyoto, Japan that is focused on the development of cellular immunotherapies for cancer. The company, founded in 2019, aims to realize cell-based therapies against cancer and other immune-related diseases by utilizing universal T cells regenerated from pluripotent stem cells. This innovative strategy is based on methods developed by Dr. Hiroshi Kawamoto of Kyoto University. Their latest achievement includes a Venture Round investment at 01 December 2022 led by Healthcare Innovation. Rebirthel operates within the realms of Biotechnology, Health Care, Health and Wellness, and Life Sciences.

Taxonomy: biopharmaceuticals, cellular immunotherapy, cancer treatment, pluripotent stem cells, cell-based therapy, immunotherapy, regenerative medicine, cancer research, T cell therapy, Kyoto University, innovation, oncology, biomedicine

Funding Rounds & Investors of Rebirthel Co.,Ltd. (1)

View All
Funding Stage Amount No. Investors Investors Date
Venture Round Unknown 1 01 Dec 2022

Latest News of Rebirthel Co.,Ltd.

View All

No recent news or press coverage available for Rebirthel Co.,Ltd..

Similar Companies to Rebirthel Co.,Ltd.

View All
Caedo Oncology AS - Similar company to Rebirthel Co.,Ltd.
Caedo Oncology AS We create improved treatment options for cancer patients through unique immunotherapy opportunities
Turnstone Biologics - Similar company to Rebirthel Co.,Ltd.
Turnstone Biologics Developing next-generation TIL-based therapies to treat and cure solid tumors.
SpecificiT Pharma - Similar company to Rebirthel Co.,Ltd.
SpecificiT Pharma Pioneering personalized cancer therapies with a novel approach using Minor Histocompatibility Antigens to target hematological cancers.
Iovance Biotherapeutics, Inc. - Similar company to Rebirthel Co.,Ltd.
Iovance Biotherapeutics, Inc. Iovance is a patient-centric, collaborative organization that is driven to change the way cancer is treated.
ImmunoCellular Therapeutics Ltd - Similar company to Rebirthel Co.,Ltd.
ImmunoCellular Therapeutics Ltd Pioneering immune-based therapies to harness the body's defenses against cancer through advanced immunotherapy development.